PRF1 and neoplasm: Engagement of the CAR by its ligand on the tumor cell results in tyrosine phosphorylation of immune-receptor activation motifs present in the cytoplasmic domain, initiating T-cell signaling and specific tumor cell lysis via the perforin/granzyme pathways.